XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Maintain radio silence DAVID!!! Shake the weak hands!!!

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Sep 24, 2021 2:07pm

119 Views

Post# 33914842

RE:RE:Maintain radio silence DAVID!!! Shake the weak hands!!!

Well said AB42 and very SAD Ceo Allen. When is Nasdaq?? after more RollBacks??

Maybe never or when the Retail Investors are taken care of and KILLED. CEO, I want you to take care of the Grassroot investors who supported XRX from day one, you have FORGOTTEN them since you are for Big Money now.

gcap1 wrote:

Anklebiter42 wrote: Loving the radio silence. Weak hands are giving up the shares. Dump the dead weigh before the party.

$4.50 maybe lower coming in the upcoming weeks ....No weak hands here at the moment just smart money cashing out and jumping off Bobs Band wagon !